The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
Authors:
- 10 July 2017
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 32 (2) , 323-331
Abstract
MLL-rearranged acute lymphoblastic leukaemia (ALL) represents an aggressive malignancy in infants (<1 year of age), associated with poor outcome. Current treatment intensification is not further possible, and novel therapy strategies are needed. Notably, MLL-rearranged ALL is characterised by a strongly deregulated epigenome and shows sensitivity to epigenetic perturbators. Here we demonstrate the in vivo efficacy of the histone deacetylase inhibitor panobinostat (LBH589) using xenograft mouse models of MLL-rearranged ALL. Panobinostat monotherapy showed strong anti-leukaemic effects, extending survival and reducing overall disease burden. Comprehensive molecular analyses in vitro showed that this anti-leukaemic activity involves depletion of H2B ubiquitination via suppression of the RNF20/RNF40/WAC E3 ligase complex; a pivotal pathway for MLL-rearranged leukaemic maintenance. Knockdown of WAC phenocopied loss of H2B ubiquitination and concomitant cell death induction. These combined data demonstrate that panobinostat cross-inhibits multiple epigenetic pathways, ultimately contributing to its highly efficacious targeting of MLL-rearranged ALL.Keywords
This publication has 46 references indexed in Scilit:
- Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemiaLeukemia, 2011
- Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJournal of Neuro-Oncology, 2011
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- WAC, a Functional Partner of RNF20/40, Regulates Histone H2B Ubiquitination and Gene TranscriptionMolecular Cell, 2011
- Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targetingBlood, 2010
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemiaGenes & Development, 2008
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell linesBlood, 2008
- Histone Crosstalk between H2B Monoubiquitination and H3 Methylation Mediated by COMPASSCell, 2007
- Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementLeukemia, 2007
- Regulation of Transcription Factor YY1 by Acetylation and DeacetylationMolecular and Cellular Biology, 2001